Cardiac arrest is one of the most critical conditions, requiring immediate and well-coordinated medical care. Every second of a medic’s work is vital to saving a patient’s life. In such situations, the Stryker LUCAS 3 cardiopulmonary resuscitation device becomes an indispensable tool for doctors and rescuers. It delivers consistent, effective chest compressions, freeing specialists’ hands for other vital procedures and improving the patient’s chance of survival.
Stryker LUCAS 3 is a modern mechanical chest compression system designed for cardiopulmonary resuscitation (CPR) in patients with no heartbeat. The device for indirect heart massage fully automates the compression process, ensuring stable depth and frequency throughout the entire period of use. Unlike manual CPR, where quality depends on the efforts of the rescuer and working conditions, LUCAS 3 operates in accordance with international medical standards. This improves blood circulation and increases the likelihood of saving the patient's life. The main tasks of the device are:
providing continuous cardiopulmonary resuscitation;
maintaining blood supply to vital organs;
reducing the burden on medical personnel;
supporting resuscitation measures in difficult conditions;
restoring normal heart activity;
increasing the effectiveness of resuscitation.
The CPR device is used during transport, in ambulances, resuscitation units, and cardiology departments. Its use proves its effectiveness and contributes to the introduction of innovative medical technologies into healthcare practice.
The device is secured to the patient using a back plate and an upper module. Once in place, the chest compression device automatically performs chest compressions. Key features of the device:
Strictly controlled compression depth and frequency.
Uniform pressure regardless of the patient's physique or the fatigue of medical personnel.
Long battery life (up to 45 minutes) and external power source.
Built-in ventilation synchronization functions.
Data transfer via Wi-Fi and Bluetooth for CPR analysis and documentation.
Stryker LUCAS automated system takes over chest compressions during cardiac arrest. A special back plate is placed on the victim's back during installation. The upper module with a compression piston is fixed to it. The design is lightweight and compact, so installation takes only a few seconds. Once activated, the device begins to perform rhythmic chest compressions. The pressure is automatically adjusted to ensure the same effect regardless of the patient's physique.
Manual cardiopulmonary resuscitation remains the primary method of support during cardiac arrest. Its effectiveness largely depends on the rescuer’s experience and physical strength. Fatigue, stressful conditions, and the need to perform other procedures can often reduce the quality of compressions. In such situations, a cardiac resuscitation device proves invaluable. Advantages of the device:
stability and continuity of the process;
elimination of the human factor;
Compatibility with medical procedures;
Minimal pauses in resuscitation;
Safety and convenience during transport;
Improved clinical outcomes
Stryker LUCAS 3 provides a high level of control, accuracy, and continuity of resuscitation, significantly surpassing manual CPR in a number of key parameters.
To appreciate the capabilities of Stryker LUCAS 3, it is important to consider the technical and functional features of the device. The device combines convenience, reliability, and modern digital technology. Key features and functions that make this device an indispensable tool during emergency care:
Compression and adjustment mechanics. The piston mechanism with a suction cup ensures stable compression and full chest recoil, as recommended by international standards (AHA/ERC). The adjustable compression rate allows you to set 102, 111, or 120 compressions per minute. Adjustable compression depth from 45 to 53 mm helps to take into account the individual characteristics of patients.
Quick and safe installation. The average delay when switching from manual to mechanical CPR is only 7 seconds. The low-profile back plate and spacious design simplify device fixation, especially on large patients. A sturdy mount keeps the person and the device in a stable position during transport.
Integration and automation. Wi-Fi and Bluetooth connectivity allow the device to be combined with LIFENET and CODE-STAT systems for report downloading and subsequent data processing. Settings tailored to the clinic's requirements help to change the frequency and depth of compressions and adjust ventilation and pause signals.
Portability and convenience. Battery or external power supply operation ensures the required duration of resuscitation measures. The compact and lightweight protective case is made of durable material and equipped with a viewing window for checking the battery, handles, and straps. It is easy to clean and has compartments for accessories.
Reliability and high efficiency. Thousands of devices around the world are used consistently in different conditions. Clinical effectiveness contributes to improved blood flow to the brain and heart, increases EtCO₂ levels, and improves the chances of ROSC.
Stryker LUCAS 3 indirect cardiac massage device is one of the most effective and reliable solutions for cardiopulmonary resuscitation. Its high adaptability, ease of use, and ability to maintain the continuity and quality of resuscitation even in the most difficult conditions significantly improve performance.
There are several leading devices on the market for mechanical cardiopulmonary resuscitation (CPR) systems, each with its own features and advantages. The table shows the main comparative characteristics of Stryker LUCAS 3 with its competitors ZOLL AutoPulse, Physio-Control LUCAS 2, and Corpuls CPR.
Characteristic |
Stryker LUCAS 3 |
ZOLL AutoPulse |
Physio-Control LUCAS 2 |
Corpuls CPR |
Compression type |
Piston mechanism |
Belt |
Piston mechanism |
Piston mechanism |
Compression rate |
102–120 per minute |
80 per minute |
100 per minute |
Up to 120 per minute |
Compression depth |
53 mm |
Depends on the patient |
50 mm |
Depends on the patient |
Suitable for defibrillation |
Yes |
Yes |
Yes |
Yes |
Suitable for catheterization |
Yes |
No |
Yes |
Yes |
Application |
Wide |
Limited |
Limited |
Limited |
Stryker LUCAS 3 cardiac resuscitation device is the most advanced and effective device among those presented, providing high-quality CPR and support during various medical procedures. ZOLL AutoPulse and Physio-Control LUCAS 2 also have their advantages, but they have certain limitations compared to LUCAS 3. Corpuls CPR is a high-quality device; however, its high cost and limited availability can be obstacles to its widespread use.
LUCAS 3 can be used in a wide range of medical situations and conditions. Most often, the equipment is required for resuscitation and anesthesiology departments. Main areas of use:
ambulance and emergency services;
hospitals and inpatient facilities;
mobile medical teams;
cardiology laboratories;
rescue services;
scientific research and clinical trials.
Stryker LUCAS 3 is a versatile solution for cardiopulmonary resuscitation across a wide range of settings, from emergency scenes to hospital care. Its ability to deliver continuous, high-quality chest compressions, along with its compatibility with other medical procedures, makes it an indispensable tool for improving patient survival after cardiac arrest.
Stryker LUCAS 3 is an innovative device that transforms the approach to cardiopulmonary resuscitation. Its high efficiency, customizability, and seamless integration with other medical procedures make it an invaluable tool in emergency medicine. Comparisons with competitors such as ZOLL AutoPulse and Physio-Control LUCAS 2 highlight LUCAS 3’s advantages in both clinical effectiveness and technological sophistication.
As a leading global marketplace for medical equipment, Bimedis provides access to the most advanced healthcare solutions. Stryker LUCAS 3 is a step forward, enabling medical personnel to operate at maximum efficiency in emergency situations and improving patient survival rates.
14.10.2025